Virginia Focus - Medicare & Alzheimers Meds
27 de oct. de 2023 ·
29m 30s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that...
mostra más
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that slow the progression of the disease, but the Centers for Medicare and Medicaid Services, also known as CMS, is setting a dangerous precedent by requiring consent from patients in a way that's never been demanded before. Now many doctors, elected leaders, and families are afraid patients will face health disparities and that the move could be expanded to limit access to other medications. Let's hear more from the Chairman of the Partnership to Fight Chronic Disease and Chairman of Health Policy and Management at Emory University, Dr. Kenneth Thorpe.
mostra menos
Información
| Autor | 640 WGST (WGST-AM) |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
